ICICI Prudential US Bluechip Equity Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 11-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Growth -24.97 -20.79 5.60 12.24 16.72 15.38
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 -7.45 -6.97 9.58 9.63 14.26 7.93

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Growth Jul 06, 2012 5.60 12.24 16.72 2.02 3,248.91
Nippon India US Equity Opportunites Fund- Growth Plan- Growth Option Jul 23, 2015 10.25 13.76 16.26 2.39 724.86
Nippon India Japan Equity Fund- Growth Plan- Growth Option Aug 26, 2014 5.80 8.03 8.74 2.46 267.43
Franklin Asian Equity Fund - Growth Plan Jan 16, 2008 10.43 2.66 4.39 2.54 239.90

Fund Holdings as on 28-February-2025

  • Gilead Sciences Inc.

  • Altria Group Inc

  • Walt Disney

  • Bristol-Myers Squibb Co

  • Corteva Inc

  • Kenvue Inc

  • Boeing Co

  • Brown-Forman Corp

  • Campbell Soup Co

  • Veeva Systems Inc

  • US Bancorp Inc

  • Pfizer Inc

  • Microchip Technology Inc.

  • Zimmer Biomet Holdings Inc

  • Nike Inc

  • Huntington Ingalls Industries Inc

  • NXP Semiconductors NV

  • Estee Lauder Cos Inc

  • Adobe Inc

  • Agilent Technologies Co Ltd

  • International Flavors & Fragrances Inc

  • Allegion plc

  • ETSY INC

  • TRANSUNION

  • United Parcel Service Inc

  • Bio-Rad Laboratories Inc

  • Medtronic Plc

  • MarketAxess Holdings Inc

  • Comcast Corporation

  • Alphabet Inc

  • Net Current Assets

  • Charles Schwab Corp

  • Amazon com

  • Amgen Inc

  • Equifax Inc.

  • Mondelez International Inc

  • Honeywell Internation India Pvt Ltd

  • Microsoft Corp

  • Northrop Grumman Corp

  • Thermo Fisher Scientific Inc

  • Danaher Corp

  • Lam Research Corporation

  • Merck & Co Inc

  • Biogen Inc

  • Constellation Brands Inc

  • TERADYNE INC

  • Autodesk

  • Masco Corp.

  • Monolithic Power Systems Inc

  • West Pharmaceutical Services Inc

  • Occidental Petroleum Corp

  • Epam Systems Inc

  • OTIS WORLDWIDE CORP

  • IDEX Corp

  • Emerson Electric

  • Cognizant Tech Solutions

  • Salesforce.Com Inc

  • Freeport-McMoRan Inc

  • Globant SA

  • ASML Holding NV-NY REG SHS

  • Qualcomm Inc.

  • The Clorox Company

  • Newmont Corp

  • TREPS

View More
  • Miscellaneous

View More
  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹3,248.91 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended down ₹-1.06(-1.7%)yesterday to ₹61.45.

Among its top 3 holdings the fund has exposure to Gilead Sciences Inc., and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100